Last news
Singleron launches the AccuraSCOPE® Single Cell Transcriptome

Singleron launches the AccuraSCOPE® Single Cell Transcriptome

COLOGNE, Germany, Jan. 30, 2024 /PRNewswire/ -- Singleron Biotechnologies, a leader in single cell multi-omic solutions for precision medicine, announced two new commercial product launches : AccuraSCOPE® Single Cell Transcriptome and Genome Library...

OKG (1499.HK) Announces Title Sponsorship of HKDAS InnoFront 2024

OKG (1499.HK) Announces Title Sponsorship of HKDAS InnoFront 2024

Chairman Ren Yunan Appointed Industry Advisor and Final Judge HONG KONG, Jan. 30, 2024 /PRNewswire/ -- Hong Kong blockchain technology-listed company OKG Technology Holdings Limited ("OKG", 1499.HK) announced today that it has become the title...

Astana Opera Opens the World of Art to Children

Astana Opera Opens the World of Art to Children

Astana Opera together with Eurasian Resources Group (ERG) presented the Children and Art social charity project. The initiative is aimed at developing an aesthetic perception of the world and creative abilities of gifted children from Kazakhstan's...

Yili Group Listed Among the 2023 Forbes China Globalization Innovators Selection Top 30 Brands

Yili Group Listed Among the 2023 Forbes China Globalization Innovators Selection Top 30 Brands

SHANGHAI, Jan. 30, 2024 /PRNewswire/ -- On January 26, 2024, the first Forbes China Globalization Innovators Selection 30&30 award ceremony was held in Shanghai. During the ceremony, the 2023 Forbes China Globalization Innovators Selection Top...

Results of the Phase III INSPIRE Study on Qilu Pharmaceutical's Iruplinalkib Published in the Journal of Thoracic Oncology

Results of the Phase III INSPIRE Study on Qilu Pharmaceutical's Iruplinalkib Published in the Journal of Thoracic Oncology

JINAN, China, Jan. 30, 2024 /PRNewswire/ -- The interim analysis results from the phase III INSPIRE study of iruplinalkib developed by Qilu Pharmaceutical, which focuses on the first-line treatment of locally advanced or metastatic anaplastic...

DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Kv1.3 Inhibitor for Immunological Diseases Including IBD and AD

DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Kv1.3 Inhibitor for Immunological Diseases Including IBD and AD

The nomination of novel Kv1.3 inhibitor DPT0218 for the treatment of various immunological diseases including IBD and AD. • DPT0218 is a gut-restricted, highly potent and selective Kv1.3 inhibitor with excellent in vivo efficacy and safety profile...

Teoayeah Roars into 2024 by Unveiling N7 Classic and N7 Pro Electric Wiggle Cars

Teoayeah Roars into 2024 by Unveiling N7 Classic and N7 Pro Electric Wiggle Cars

HOUSTON, Jan. 30, 2024 /PRNewswire/ -- Succeeding a uniquely impactful journey in innovation in kids' toys with licensed Lamborghini Roadsters, Licensed Toyota models, and Harley-Davidson Jeep, Teoayeah returns in 2024 with two new models – the...

Thaioil has achieved the highest ESG score in the Oil & Gas Refining and Marketing Industry for the 8th year and recognized as a DJSI member for the 11th consecutive year

Thaioil has achieved the highest ESG score in the Oil & Gas Refining and Marketing Industry for the 8th year and recognized as a DJSI member for the 11th consecutive year

BANGKOK, Jan. 30, 2024 /PRNewswire/ -- Thai Oil Public Company Limited has achieved the highest score for sustainable development in the Oil & Gas Refining and Marketing Industry for the 8th year from the Dow Jones Sustainability Indices (DJSI)...

1 ... 46 47 48 49 50 51 52 53 54 ... 1190
menu
menu